Columbia Financial launched a firm-commitment underwritten offering at $10 per share to sell unsubscribed second-step conversion shares, targeting $281 million to $769 million. Completion depends on regulatory approvals and sale of at least 142,375,000 shares, including merger consideration to Northfield Bancorp. The deal underscores merger-related financing risk and possible effects on TBV and EPS timing.
New equity issuance creates near-term dilution pressure and potential negative TBV impact; execution risk and merger timing add volatility. Historical bank dilutions around mergers often weigh on share price until closing certainty improves.
Near-term dilution risk from the equity raise; potential long-term accretion if the Northfield merger closes.
Category Type: M&A. The article documents a financing maneuver tied to a pending Northfield merger, a classic corporate development event in mid-sized banks that can impact CLBK’s capital structure and future earnings trajectory.